- Ontario Canada BHR covered by OHIP at Cleveland Clinic by Dr. Brooks
- 20 Years of Hip Resurfacing – BHR Past, Present and Future by Dr. Edwin Su 2017
- Birmingham Hip Resurfacing 20 Year Video
- Causes of Failure of Hip Resurfacing and Early Update with Metal on XL Polyethylene Hip Resurfacing by Mr. McMinn 2017
- The McMinn Centre Celebrates 20 Years of Birmingham Hip Resurfacing
- Dr. Laskowski Discusses Hip Resurfacing and BHR
- Mr. McMinn Interview about BHR Birmingham Hip Resurfacing 1999
- Birmingham Hip Resurfacing Part III – Benefits to patients
- Birmingham Hip Resurfacing Part II – Surgery Procedure
- Birmingham Hip Resurfacing Part I – Symptoms & Diagnosis
- Birmingham Hip Resurfacing vs Total Hip Replacement
- Arizona – Smith & Nephew Birmingham Hip Resurfacing Action Dismissed
- BHR Birmingham Hip Resurfacing Information
- Smith & Nephew Awarded Summary Judgement in BHR Case
- Outcomes of the Birmingham Hip Resurfacing System Study 2016
- Sign McMinn Petittion for
August 1, 2016 A Wisconsin federal judge has awarded Smith & Nephew Inc. summary judgment in a case involving its Birmingham Hip Resurfacing implant, finding the plaintiffs failed to present expert testimony that the device was defective.
What is a Summary Judgement:
A final decision by a judge, upon a party’s motion, that resolves a lawsuit before there is a trial. The party making the motion marshals all the evidence in its favor, compares it to the other side’s evidence, and argues that there are no “triable issues of fact.” Summary judgment is awarded if the undisputed facts and the law make it clear that it would be impossible for the opposing party to prevail if the matter were to proceed to trial.… Read the rest
Sign McMinn Center Petition to Smith & Nephew PLC: Reversal of decision to withdraw Birmingham Hip Resurfacing implants for women by clicking on link below:
The McMinn Centre has been overwhelmed by contact from concerned male and female patients who are devastated by Smith & Nephew’s decision and its implications. Many of our female patients have stated that after successful BHR surgery with Mr McMinn, they were planning to have the same operation on their other hip when it became necessary. Now this is not possible due to Smith & Nephew’s life-changing decision.… Read the rest
The First Generation Metal-on-Metal bearings manufactured in the 1950s and 1960s were produced by the investment casting process (Ring and McKee Farrar prostheses). From these devices we have recorded the longest benign clinical history of cobalt chrome alloys with extremely low linear wear rates.The BHR™ is produced using the investment casting process from high carbon cobalt chrome in the As Cast micro-structural condition.Wear studies have shown that Cobalt Chrome in its As Cast form has superior wear resistance to other forms of the alloy.
The BHR™ has a hemispherical cup design with a cast-in porous ingrowth surface called Porocast™. This ingrowth surface does not require a heat treatment to attach the beads and therefore preserves the carbide structure.
Clearance is the term used to describe the effective gap between the femoral head and acetabular cup in a Metal-on-Metal bearing. It is calculated by subtracting the radius of the … Read the rest
Dr. Kurtz had an article online that had concerns about the head neck rations of hip resurfacing compared to total hip replacement. We wanted to provide potential hip resurfacing patients with opinions of other top resurfacing surgeons to explain their views.
Very nice to hear from you. I’m sorry for the delay in
I have read over the material at this website many
A SERIES OF 110 CONSECUTIVE HIPS WITH A MINIMUM FIVE-YEAR CLINICAL AND RADIOLOGICAL FOLLOW-UP
G. N. A. Heilpern, MRCS, Orthopaedic Specialist Registrar1; N. N. Shah, FRCS, Senior Clinical Fellow2; and M. J. F. Fordyce, FRCS, Consultant Orthopaedic Surgeon31 King’s College Hospital, Denmark Hill, London SE5 9RS, UK. 2 Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH, UK. 3 Kent and Sussex Hospital, Mount Ephraim, Royal Tunbridge Wells, Kent TN4 8AT, UK.
We report the outcome at a minimum of five years of 110 consecutive metal-on-metal Birmingham Hip Resurfacing arthroplasties in 98 patients. The procedures were performed between October 1999 and June 2002 by one surgeon. All patients were followed up clinically and radiologically. The mean follow-up was 71 months (60 to 93). Revision of either component was defined as failure.
The mean Harris Hip score at follow-up was 96.4 (53 … Read the rest
New Promising Data on S&N’s BIRMINGHAM HIP™ System
By Elizabeth Hofheinz, MEd, MPH December 10, 2007
No more wondering Down Under. The data is in. Smith & Nephew, Inc.’s Orthopaedic Reconstruction business is announcing the release of positive six-year clinical data by the Australian Orthopaedic Association National Joint Replacement Registry on the company’s BIRMINGHAM HIP Resurfacing System (BHR™). According to the company, the BHR, which has now been implanted in nearly 80,000 patients in 26 countries, conserves more of a patient’s bone than a traditional hip replacement, enabling younger, more active patients to undergo hip replacement surgery while preserving all future surgery options, including a primary hip replacement. The design of the BIRMINGHAM HIP Resurfacing System also offers patients a reduced risk of dislocation. The report revealed that the BHR device has the highest hip resurfacing system survivability rate among all of its established competitors for which data… Read the rest
BHR 10 years of Data
The first BHR was implanted in July 1997 and it is unchanged until present day.
96.1% survivorship overall
McMinn 99.8% at 8 years
|Treacy 99% at minimum 5 years|
|Shimmin et al 99.14% at 3 years|
Oswestry Cohort, FDA approval Data 2006 98.7% at 4 years
U.S. Statistics as of 10/2007
|There have been 1000 surgeons trained to date|
Only about 50% of those surgeons actually do the procedure (they are all however listed on the Smith &Nephew website
|There have been 7000 BHR’s installed in the U.S. to date|
Oswestry Registry 5000
BHR’s to date 2007
|99.8% survivorship at 3.3 years|
|95.7 % at 8 years|
|99.5% of these patients were happy at 5 years.|
|3227 were male, 1602 female, there were 50 revisions, 14 were fractures, 14 collapsed neck|
95.7% satisfied at 8 years
|The 1.5% neck fracture – due to learning curve.|
Dr. Kurtz had an article online that had concerns about the head neck rations of hip placement. We wanted to provide potential hip resurfacing patients with opinions of other top resurfacing surgeons to explain their views.
Thanks for the mail. I read Dr. Kurtz thoughts on hip resurfacing in his
In short , his concerns only underline the fact that bad results of
However many patients especially young osteoarthritis will have FAI ( Femoro
Published on July 2, 2013
Derek McMinn presents a talk on the Birmingham Hip
Resurfacing (BHR) and the alternative options for hip joint replacement
surgery. Starting with the development of the BHR, Mr McMinn goes on to
discuss survivorship rates and revisions, cancer, metal ions, the DePuy ASR
disaster, Delta Ceramic and new development Polymix. The presentation is
dedicated to the late Vicky Marlow, a fantastic patient advocate and voice
of support in the hip resurfacing community.
In this lecture, Mr. McMinn talks about the development of the metal-on-metal
hip resurfacing implants he has designed, looking at survival rates and
pilot studies. Press-fit, cemented and un-cemented implants were all tested
and the best outcome was a single heat-treated hybrid un-cemented cup and a
cemented femoral component. The Birmingham Hip Resurfacing (BHR) was
developed by a company formed by Mr McMinn and Ronan Treacy after
relationships with earlier hip resurfacing manufacturers … Read the rest
Birmingham Hip Metal-on-Metal Resurfacing – 94.5% Ten-Year Survivalhttp://web.jbjs.org.uk/content/94-B/3/315.abstractResults from an independent centreNovember 1, 2011
We report the findings of an independent review of 230 consecutive Birmingham hip resurfacings (BHRs) in 213 patients (230 hips) at a mean follow-up of 10.4 years (9.6 to 11.7). A total of 11 hips underwent revision; six patients (six hips) died from unrelated causes; and 13 patients (16 hips) were lost to follow-up. The survival rate for the whole cohort was 94.5% (95% confidence interval (CI) 90.1 to 96.9). The survival rate in women was 89.1% (95% CI 79.2 to 94.4) and in men was 97.5% (95% CI 92.4 to 99.2). Women